We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current EVGN market cap is 32.39M. The company's latest EPS is USD -0.4724 and P/E is -1.35.
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 348k | 75k | 333k | 237k | 641k |
| Operating Income | -4.67M | -6.86M | -6.26M | -8.06M | -6.8M |
| Net Income | -3.71M | -6.23M | -6.6M | -8.28M | -6.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 753k | 1.04M | 930k | 5.18M | 5.64M |
| Operating Income | -21.17M | -24.81M | -30.95M | -26.94M | -26.51M |
| Net Income | -18.11M | -23.37M | -27.79M | -26.64M | -23.88M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 57.64M | 64.65M | 92.78M | 66.88M | 49.48M |
| Total Liabilities | 10.88M | 9.71M | 10.67M | 12.15M | 20.98M |
| Total Equity | 46.76M | 54.94M | 82.1M | 54.73M | 28.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 71.36M | 71.92M | 76.3M | 56.13M | 51.1M |
| Total Liabilities | 11.15M | 15.03M | 12.88M | 21.34M | 22.42M |
| Total Equity | 60.22M | 56.88M | 63.42M | 34.79M | 28.69M |
| Quarter End | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.36M | -5.48M | -4.69M | -7.71M | -6.24M |
| Investing | 6.15M | 3.25M | -29.76M | 11.98M | 304k |
| Financing | -66k | -2k | 27.49M | -100k | 53k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.67M | -19.51M | -24.72M | -23.68M | -21.58M |
| Investing | 37.14M | 9.42M | -20.57M | 13.27M | -4.54M |
| Financing | 9.31M | 20.37M | 30.28M | 9.34M | 18.15M |
| Market Cap | 32.39M |
| Price to Earnings Ratio | -1.35 |
| Price to Sales Ratio | 5.73 |
| Price to Cash Ratio | 1.56 |
| Price to Book Ratio | 1.13 |
| Dividend Yield | - |
| Shares Outstanding | 50.55M |
| Average Volume (1 week) | 62.93k |
| Average Volume (1 Month) | 79.96k |
| 52 Week Change | 12.42% |
| 52 Week High | 1.44 |
| 52 Week Low | 0.4502 |
| Spread (Intraday) | 0.17 (22.09%) |
| Company Name | Evogene Ltd |
| Address |
13 gad feinstein street, park rehovot rehovot, center 7414002 |
| Website | https://www.evogene.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
